Rechercher des projets européens

"This project will focus on the preclinical development of a DNA vaccine for human visceral leishmaniasis. The project is based upon the DNA vaccine technology and immunomodulators developed at Mologen AG (Berlin, Germany), which are in clinical development for cancer and 3-5 known antigens that already have demonstrated profiles of protection in animal models of leishmaniasis. Antigens will be se ...

"Visceral leishmaniasis (VL) & cutaneous leishmaniasis (CL) are parasitic diseases transmitted to humans by the bite of infected insects (sand flies). VL is fatal if not treated and CL may cause facial disfigurement both are more likely to affect children under 15 years old in European as well as S. Mediterranean countries. Precise figures are not available but reports suggest that between 36,000 ...